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ABSTRACT 
Objective: The objective of this study was attempted to screen the production of L-asparaginase from bacteria isolated from soil samples and its 
enzymatic activity.  
Methods: Screening of L-asparaginase was performed using phenol red indicator growth medium from which the positive strains were chosen 
based on the colour change. The enzyme production of L-asparaginase was established by submerged fermentation followed by the molecular 
detection of the efficient bacterial strains. 
Results: The enzyme production was undertaken by submerged fermentation with the evaluation of enzymatic activity and protein content. This 
revealed that the strain Escherichia coli CTLS20 produced a higher yield of L-asparaginase (30.22 IU/mg), 16.91 µg/ml of protein with the specific 
activity of 1.787 IU/mg when compared with other bacterial strains. The efficient bacterial strains were also confirmed by 16S rRNA sequence as 
Escherichia coli, Acinetobacter baumnnii, Klebsiella pneumoniae and the phylogenetic tree construction revealed the evolutionary relationship of the 
bacterial strains.  
Conclusion: This study indicated that the bacterial strain E. coli CTLS20 had the ability for the higher production of L-asparaginase. This novel 
higher yielding bacterial asparaginase is highly desirable as better alternatives in cancer therapy. 
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INTRODUCTION 
An antitumor enzyme, L-Asparaginase is a significant group of 
therapeutic enzymes that accounts for about 40% of the enzyme 
sales and one-third of the worldwide requirement [1]. L-
asparaginase can be effectively treating Acute Lymphoblastic 
Leukemia (ALL) and Lymphosarcoma that were approved by the 
Food and Drug Administration (FDA) and World Health 
Organization (WHO) organizations [2]. The potential interests in this 
enzyme had also increased with the report when it serves as an anti-
neoplastic agent, used for the treatment of Hodgkin disease, chronic 
lymphocytic leukemia, Reticlesarcoma, and Melanosarcoma [3, 4]. L-
Asparaginase (EC 3.5.1.1) belongs to a group of homologous 
amidohydrolases family, which catalyses the hydrolysis of the amino 
acid L-asparagine to L-aspartate and ammonia [5].  
These L-asparaginases were found in both prokaryotic and 
eukaryotic organisms. L-asparaginase production by the microbial 
source is beneficially owing to the cost effective and eco-friendly 
nature. The microbial production of L-asparaginase was first 
reported in Escherichia coli [6] whereas the other bacterial strains 
such as Serratia marcescens [7], Corynebacterium glutamicum [8], 
Staphylococcus aureus [9], Erwina cartovora [10], Bacillus subtilis 
[11] and Pseudomonas aeruginosa [12] have also been reported. The 
fungal strains Aspergillus nidulans [13] and Aspergillus terreus [14] 
have been reported to produce L-asparaginase. The cytotoxicity of 
leukemic cells and tumor inhibitory activity has been demonstrated 
only with L-asparaginase from E. coli, Erwinia aroideae and Serratia 
marcescens [15]. The finding by Mashburn and Wriston that L-
asparaginase derived from Escherichia coli antitumor activity was 
the same as guinea pig serum and awake the possibility of large 
scale production of the enzyme for ultimate clinical trial [16]. L-
asparaginase from E. coli, the high yields of asparaginase and 
purification of the enzyme, were in sufficient quantity for human 
therapy [17]. L-Asparaginase was produced throughout the world by 
submerged fermentation [18]. It was caused by the yield of the 
product is several times higher than that other techniques. In other 
hands, the enzyme properties of L-asparaginase might vary with the 
microbial source and also the prolonged administrations of L-
asparaginase, which causes an anaphylactic shock or neutralization 
of the drug effect [19]. Therefore, there is a continual need to find 
out new microbial sources to obtain high-yielding of L-asparaginase 
producing strains for their therapeutic and industrial applications 
[20]. In the present study, L-asparaginase enzyme was available 
from the source of farm soil and the molecular characterization of 
the microbial strains producing L-asparaginase was determined. 
MATERIALS AND METHODS 
Collection of soil samples 
The soil samples were perceived from the farms of Tamil Nadu 
Agricultural University, Coimbatore. The soil was clay loam black 
cotton soil, rich in lime and potash with neutral alkalinity. The 
samples were serially diluted and plated on nutrient agar plates 
[21]. The plates were incubated at 37 °C for 24 h. The bacterial 
isolates were confirmed with the help of Bergey’s Manual of 
Determinative Bacteriology [22].  
Screening of L-asparaginase by plate method 
The bacterial isolates were screened for preliminary L-
asparaginase activity using the modified-M9 medium. The medium 
contained Na 2HPO 4.2H2O, 6 g; KH2PO 4, 3 g; NaCl, 0.5 g; L-
asparagine, 10 g; 1M MgSO 4.7H2O, 2 ml; 0.1 M solution of 
CaCl2.2H2O, 1 ml; 20 % glucose stock, 10 ml; agar 20 g/l of 
distilled water. The medium was supplemented with 0.005 % 
phenol red dye and the pH was adjusted to 6.2. The bacterial 
isolates were inoculated and incubated at 37 °C for 48 h. After 
incubation, L-Asparaginase activity was identified based on the 
intensity of pink color produced on the streaked plates [23]. 
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Screening of L-asparaginase by submerged fermentation 
The bacterial strains which showed excellent activity on modified-
M9 solid media were further used for the production of L-
asparaginase through submerged fermentation. 50 ml of M9 broth 
was inoculated with bacterial suspension and incubated at 37 °C for 
18-20 h on a rotary shaker [24]. Seventy-two hour old cultures were 
collected and centrifuged at 4 °C for 30 min at 10000 rpm. The pellet 
was washed three times with sterile, cold distilled water by 
centrifuging at 10000 rpm for 15 min at 4 °C. The washed pellets 
were suspended in 0.05 M Tris-hydrochloric acid buffer pH 8.6. 
Aliquots of the suspended cells were prepared and sonicated by 
keeping in ice. The sonicated sample was then pooled and 
centrifuged at 12000 rpm for 15 min at 4 °C. The supernatant was 
collected and used as a source of the crude enzyme [25].  
Assay of L-asparaginase 
The samples were mixed with 0.04 M L-asparagine in 0.05 M Tris buffer, 
pH 7 and 200 µl of sample mixture and incubated for 10 min at 37 °C for 
the enzymatic reaction. The reaction was incubated with 50 µl of 1.5 M 
TCA and centrifuged before the addition of Nessler’s reagent to measure 
the released ammonia after L-asparagine hydrolysis. The measurements 
were done spectrophotometrically at 450 nm.  
International unit (IU) for enzyme activity 
One unit of enzyme activity was defined as the amount of enzyme 
required to release 1 mM of ammonia per minute per ml 
[μm/ml/min]. 
Estimation of protein 
Protein content was quantified by the method of Lowry et al., [26] 
using bovine serum albumin as the protein standard.  
Molecular identification of bacterial strains 
The screened bacteria were then identified by 16S rRNA gene 
sequencing method. The extraction of DNA from the bacterial 
species was carried out by the method of Marmur [27] and the 
purity of DNA was checked by spectrophotometer at 260/280 
values. The extracted DNA was viewed by gel documentation unit 
using 0.8 % agarose gel. The extracted DNA was amplified by using 
polymerase chain reaction (PCR). The Universal Primer sequences 
were forward primer (5’-GAGTTTGATCCTGGCTCAG-3’) and reversed 
primer (5’-ACGGCTACCTTGTTACGACTT-3’). The PCR amplification 
cycle was carried out with an Eppendrof Master Cycler Personal. The 
amplification cycle consists 94 °C for 5 min, 30 cycles of 94 °C for 1 
min, 56 °C for 1 min, 72 °C for 2 min and a final extension at 72 °C for 
10 min. To visualize the amplified PCR product 16 µl volume of the 
amplified products were subjected to electrophoresis in Tris-borate-
EDTA (1X TBE) pH 8 on a 0.8 % agarose gel incorporating 0.01 % 
ethidium bromide, 8 µl of the DNA ladder (1000bp) were run in 
parallel to the samples in each gel. The amplified PCR products were 
visualized under a gel documentation unit. 
Phylogenetic tree 
The 16S rRNA gene sequences were compared for similarity with 
the reference species of bacteria contained in the genomic database 
bank using the NCBI BLAST. Multiple alignments of the sequences 
were performed using the Clustal W program. The phylogenetic tree 
was constructed by using treeing algorithms in Mega 5 software. 
RESULTS  
Forty bacterial isolates obtained as pure cultures were examined for 
L-asparaginase production using modified M9 medium. In the 
modified M9 plate media, only five strains showed the ability of the 
production of L-asparaginase, and this was based on the colour 
change due to change in pH of the medium (Plate 1). Asparaginase 
causes the hydrolysis of L-asparaginase into L-aspartic acid and 
ammonia. The release of ammonia changes pH due to phenol red 
indicator; it has a pale yellow color with the acidic condition, as the 
pH changes to alkaline it turns to pink. 
 
 
Plate 1: Pink colour colonies on modified M9 medium 
 
L-Asparaginase production by submerged fermentation and the 
crude enzyme was used for the enzymatic activity. L-asparaginase 
assay was done by the determination of ammonia liberated from L-
asparagine by the Nessler’s reaction. The intracellular enzyme was 
extracted by sonication method. The strain CTLS20 was noted to 
produce the highest L-Asparaginase activity followed by CTLS30 
among all other strains. In contrast, the minimum L-asparaginase 
production was found in strain CTLS25 (table 1). 
Then these efficient L-asparaginase producing organisms were 
supported by 16S rRNA sequencing. The genomic DNA was isolated 
from the efficient strains and PCR amplification was performed. The 
result is obtained by 16S rRNA gene sequencing, and BLAST 
indicated that the bacterial strains CTLS20, CTL30 and CTL39 were 
similar to Escherichia coli, CTLS21 as Acinetobacter baumannii and 
CTLS25 as Klebsiella pneumoniae.  
The phylogenetic tree was constructed using MEGA 5 software (fig. 1 
to fig. 5). The 16S rRNA sequences were deposited in Genbank and 
accession number KJ683064, KJ676683 and KJ683063 (E. coli), 
KJ676684 (A. baumannii) and KJ676685 (K. pneumoniae) were 
obtained. The results were proved that the highest yielding of L-
asparaginase by E. coli strain. 
 
Table 1: Specific activity of L-asparaginase produced by the bacterial strains 





Specific activity  
(IU/mg) 
1 E. coli CTLS20 30.22 16.91 1.787 
2 A. baumannii CTLS21 7.9 17.94 0.440 
3 K. pneumoniae CTLS25 4.62 17.31 0.266 
4 E. coli CTL30 29.2 20.37 1.433 
5 E. coli CTL39 9.16 17.84 0.513 
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Fig. 1: Phylogenetic tree of Acinetobacter baumannii CTLS21 
 
 
Fig. 2: Phylogenetic tree of Klebsiella pneumonia CTLS25 
 
 
Fig. 3: Phylogenetic tree of Escherichia coli CTL 30 
 
 
Fig. 4: Phylogenetic tree of Escherichia coli CTL 39 
 
 
Fig. 5: Phylogenetic tree of Escherichia coli CTLS 20 
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Asparaginase is the cornerstone for treatment of Acute 
Lymphoblastic Leukemia (ALL) and used for treatment in all 
pediatric regimens [28]. L-asparagine is an essential amino acid for 
the growth of tumor cells whereas the normal cells do not require 
the growth. Even though the tumor cells get deprived and cannot 
survive in the presence of L-asparaginase [29]. Thus, the enzyme L-
asparaginase has a great benefit in the cancer treatment.  
This study made an attempt to isolate asparaginase producing 
bacteria from farm soil because an earlier study has clearly shown 
that soil can provide a rich source of L-asparaginase producing 
bacteria [30]. For screening of asparaginase producing bacteria on a 
modified-M9 agar medium was used. This study was correlated to 
Pradhan et al., [31] which examined L-asparaginase producing 
bacterial strains through the pink zone formation in the modified-
M9 medium. Patil et al., [2] and Ghasemi et al., [23] used in M9 
modified agar plug screening based on a change in pH which turned 
phenol red from yellow to pink and indicated asparaginase activity. 
Thus, the plate assay is a sensitive but also a rapid method for the 
screening of asparaginase producing bacterial strains. 
L-asparaginase assay was done by the determination of ammonia 
liberated from L-asparagine by the Nessler’s reaction. Imada et al., 
[32] and Ahmad et al., [33] reported that the enzyme activities of L-
asparaginase in culture filtrate were estimated by Nesslerization 
process. The strain CTLS20 (E. coli) was observed to produce the 
highest L-asparaginase activity compared with all other bacterial 
strains. These findings were strongly correlated to the first report of 
L-asparagines obtained from E. coli in 1957. The author Mashburn et 
al., [6] purified the L-asparaginase from E. coli and demonstrated its 
tumor inhibitory activity. Cedar et al., [34] reported that the L-
asparaginase was synthesized at constant rates by E. coli under 
anaerobic conditions. Similarly, Barnes et al., [35] revealed E. coli A-
1 produces L-asparaginase from culture fluid when grew in a small 
fermentor while the crystal structure of the enzyme from E. coli was 
studied by Swain et al., [36]. Likewise, Jain et al., [37] observed L-
asparaginase from E. coli (VRY-15) reported the highest specific 
activity of L-asparaginase of about 19.56 μl/mg whereas Muharram 
et al., [38] observed E. coli had a potential for asparaginase 
production. The findings of this study also correlate to few of the 
studies which observed L-asparaginase from Acinetobacter sp. and 
Klebsiella pneumoniae [12, 39].  
In view of literature reports, the yield of L-asparaginase in this study 
was higher than other studies while those studies were comparing 
their strains with the reference organisms. Devi et al., [40] found 
that maximum enzyme activity of Erwina carotovora MTCC 1428 
was 0.176 U/8 h at 300 rpm agitations. While Pradhan et al., 2013 
[31] identified Bacillus subtilis strain HSWX88 (23.8 IU/ml) was 
higher than the reference organisms. These results were totally 
contrasted with the present study that the strain E. coli CTLS20 had 
produced a higher yield of L-asparaginase (30.22 IU/mg), 16.91 
µg/ml of protein with the specific activity of 1.787 IU/mg. It 
indicated that bacterial strain E. coli CTLS20 could be a potential to 
produce a higher yield of intracellular L-asparaginase. Further, the 
purified enzyme from these bacterial strains has been supplied and 
employed in the clinical application for acute leukemia and another 
malignant neoplasm in human. The production process of these 
strains may be optimized for economizing the process. 
CONCLUSION 
The enzyme L-asparaginase has excellent therapeutic properties and 
clinically acceptable for its anti-tumor activity. The present study 
indicated that the microorganisms were capable of producing L-
asparaginase especially the motile E. coli had the ability for the 
higher production of L-asparaginase. This novel higher yielding 
bacterial asparaginase is highly desirable as better alternatives in 
cancer therapy. Thus, these organisms may be exploited for large-
scale production of L-asparaginase.  
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